Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Thymoxamine adverse reaction (disorder) |
Causative agent (attribute) |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to moxisylyte |
Causative agent (attribute) |
False |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing moxisylyte (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Moxisylyte 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thymoxamine hydrochloride [erectile dysfunction] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thymoxamine hydrochloride [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thymoxamine 0.5% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing moxisylyte in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing moxisylyte in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Topical oral thymoxamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing moxisylyte in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to moxisylyte |
Causative agent (attribute) |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Moxisylyte 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Moxisylyte 40 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Moxisylyte hydrochloride (substance) |
Is modification of (attribute) |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thymoxamine 0.5% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Moxisylyte 40 mg oral tablet |
Has precise active ingredient |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing moxisylyte in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Moxisylyte only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only moxisylyte in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only moxisylyte in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only moxisylyte in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Moxisylyte (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |